TrialTherapeutic innovation & regulatory science2023
Efficacy Endpoints in Phase II Clinical Trials for Meningioma: An Analysis of Recent Clinical Trials.
Shinya Watanabe et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papertrialcites it